Outlook Therapeutics names new chairman amid product launch
ISELIN, N.J. - Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company with a current market capitalization of $50.3 million, announced the appointment of Faisal G. Sukhtian as Chairman ...
Outlook Therapeutics® Appoints Faisal G. Sukhtian as Chairman of the Board of Directors
On behalf of the Board of Directors, management, and employees of Outlook Therapeutics, I want to extend my deepest gratitude ...
Clearside Biomedical announces medical meeting presentations on pipeline
Clearside Biomedical (CLSD) announced recent and upcoming presentations at ophthalmic medical meetings highlighting Clearside’s suprachoroidal ...